Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Medical Marihuana Group was a Canadian medical cannabis-related company that provided medical consulting services focused on patients' clinical and litigation needs associated with cannabinoid therapy. The business appears to have operated alongside a related consulting entity, Medical Marijuana Group Consulting, and was part of Golden Leaf Holdings' Canadian operations. MMG was a private company based in Komoka, Ontario, and operated in the healthcare services segment rather than as a traditional drug-development biotech. In late 2019, Sensi Brands acquired MMG and the related Canadian operations, after which MMG was integrated into Sensi Brands' Canadian cannabis platform. The company does not appear to have maintained an independent drug pipeline or therapeutic development program.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Medical Marihuana Group.